Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Expert Panel:
![michael_keating.edit michael_keating.edit](https://www.cllglobal.org/wp-content/uploads/elementor/thumbs/michael_keating.edit_-qcwl9vzn3qcda7v1xdxarsz6buuvpopy5p4lmal780.jpg)
Dr. Michael Keating, Founder, CLL Global Research Foundation
![xwilliam_wierda.resize400 xwilliam_wierda.resize400](https://www.cllglobal.org/wp-content/uploads/elementor/thumbs/xwilliam_wierda.resize400-qcwl9v1swwb2ylwf2vio7b7pqgzihzm7tkh450mle8.jpg)
Dr. William Wierda, President & CEO, CLL Global Research Foundation
![Portraits Portraits](https://www.cllglobal.org/wp-content/uploads/elementor/thumbs/Portraits-e1697123361909-qdrbk5im9hhwppzoiibevsacgo9o6c8b3em9f3sez4.jpg)
Dr. Alessandra Ferrajoli, Associate Medical Director, Department of Leukemia, MD Anderson Cancer Center
![jeff.edit jeff.edit](https://www.cllglobal.org/wp-content/uploads/elementor/thumbs/jeff.edit_-qcwl9vzn3qcda7v1xdxarsz6buuvpopy5p4lmal780.jpg)
Jeff Folloder, Moderator and CLL patient advocate